Andrew Hykes, Chief Operating Officer at Inari Medical, Inc. (NARI), sold 8,200 shares at $76.58 ($627K) on 2022-01-18, disclosed to the SEC on 2022-01-20.
Open-market sale of $627k NARI by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.46 | 1,224 | $92K | 14.7% |
| 2 | $75.46 | 1,224 | $92K | 14.7% |
| 3 | $76.58 | 1,976 | $151K | 24.1% |
| 4 | $76.58 | 1,976 | $151K | 24.1% |
| 5 | $77.31 | 1,400 | $108K | 17.3% |
| 6 | $78.29 | 400 |
| $31K |
| 5.0% |
| Total | $76.45 avg | 8,200 | $627K | 100% |
| Filing → |
| NARI | SELL | 2024-10-31 | $150K | — | Filing → |
| NARI | SELL | 2024-08-22 | $150K | — | Filing → |
| NARI | SELL | 2024-07-24 | $166K | — | Filing → |